Becky L. Phan

723 total citations
17 papers, 523 citations indexed

About

Becky L. Phan is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Becky L. Phan has authored 17 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 9 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Becky L. Phan's work include Inflammatory Bowel Disease (13 papers), Microscopic Colitis (8 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Becky L. Phan is often cited by papers focused on Inflammatory Bowel Disease (13 papers), Microscopic Colitis (8 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Becky L. Phan collaborates with scholars based in United States, Australia and Denmark. Becky L. Phan's co-authors include Marla C. Dubinsky, Nanci Pittman, Keith Benkov, Jacqueline Jossen, Diane R. Mould, Namita Singh, Shervin Rabizadeh, Michael T. Dolinger, Jeffrey S. Hyams and Katrine Carlsen and has published in prestigious journals such as Gastroenterology, Inflammatory Bowel Diseases and Journal of Pediatric Gastroenterology and Nutrition.

In The Last Decade

Becky L. Phan

17 papers receiving 517 citations

Peers

Countries citing papers authored by Becky L. Phan

Since Specialization

Citations

This map shows the geographic impact of Becky L. Phan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Becky L. Phan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Becky L. Phan more than expected).

Fields of papers citing papers by Becky L. Phan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Becky L. Phan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Becky L. Phan. The network helps show where Becky L. Phan may publish in the future.

Co-authorship network of co-authors of Becky L. Phan

This figure shows the co-authorship network connecting the top 25 collaborators of Becky L. Phan. A scholar is included among the top collaborators of Becky L. Phan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Becky L. Phan. Becky L. Phan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity 2022 ·Inflammatory Bowel Diseases ·Marla C. Dubinsky, (unknown), Becky L. Phan, (unknown), (unknown), Diane R. Mould	53
2	P082 ANTI-TNF EFFICACY AFTER PRIMARY VEDOLIZUMAB FAILURE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE 2020 ·Inflammatory Bowel Diseases ·Michael T. Dolinger, (unknown), Becky L. Phan, Stephanie Pan, Marla C. Dubinsky	2
3	Use of Small Bowel Ultrasound to Predict Response to Infliximab Induction in Pediatric Crohn’s Disease 2020 ·Journal of Clinical Gastroenterology ·Michael T. Dolinger, (unknown), Becky L. Phan, Henrietta Kotlus Rosenberg, John Rowland, Marla C. Dubinsky	21
4	Sa1893 PRIOR IMMUNOGENICITY TO ANTI-TNF BIOLOGICS IS NOT ASSOCIATED WITH INCREASED ANTI-DRUG ANTIBODIES TO VEDOLIZUMAB OR USTEKINUMAB 2020 ·Gastroenterology ·(unknown), Zachary A. Borman, Becky L. Phan, Jiayi Ji, Marla Dubinsky, Ryan C. Ungaro	1
5	240 REAL-WORLD APPLICATION OF AN ADAPTIVE DOSING DASHBOARD REVEALS ACCELERATED INDUCTION DOSING OF INFLIXIMAB IS NECESSARY IN MOST IBD PATIENTS AND IMPROVES THERAPUETIC OUTCOMES 2020 ·Gastroenterology ·Marla Dubinsky, Becky L. Phan, (unknown), Diane R. Mould	2
6	P082 ANTI-TNF EFFICACY AFTER PRIMARY VEDOLIZUMAB FAILURE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE 2020 ·Gastroenterology ·Michael T. Dolinger, (unknown), Becky L. Phan, Stephanie Pan, Marla Dubinsky	1
7	Coping Among Parents of Teens With Inflammatory Bowel Disease 2019 ·Gastroenterology Nursing ·Katrine Carlsen, Becky L. Phan, Nanci Pittman, Keith Benkov, Marla C. Dubinsky, Laurie Keefer	5
8	Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease 2019 ·Journal of Crohn s and Colitis ·Ryan C. Ungaro, Andrés Yarur, Jacqueline Jossen, Becky L. Phan, (unknown), Priya Sehgal, Kanika Kamal, (unknown), Poonam Beniwal‐Patel, Caroline S. Fox, Amir Patel, (unknown), Anjali Jain, Dan J. Stein, Snehal Naik, Marla C. Dubinsky	52
9	Real World Experience With Ustekinumab in Children and Young Adults at a Tertiary Care Pediatric Inflammatory Bowel Disease Center 2019 ·Journal of Pediatric Gastroenterology and Nutrition ·(unknown), Michael T. Dolinger, Keith Benkov, David Dunkin, Jacqueline Jossen, Joanne Lai, Becky L. Phan, Nanci Pittman, Marla C. Dubinsky	78
10	Dashboards for Therapeutic Monoclonal Antibodies: Learning and Confirming 2018 ·The AAPS Journal ·Diane R. Mould, Richard N. Upton, (unknown), Becky L. Phan, (unknown), Marla C. Dubinsky	13
11	Proactively Optimized Infliximab Monotherapy Is as Effective as Combination Therapy in IBD 2018 ·Inflammatory Bowel Diseases ·Sara Lega, Becky L. Phan, (unknown), (unknown), (unknown), Nanci Pittman, Keith Benkov, Marla C. Dubinsky	70
12	Mo1838 - Pharmacokinetic Dashboard-Driven Infliximab Dosing in IBD:A Prospective Interventional Study 2018 ·Gastroenterology ·Marla Dubinsky, Becky L. Phan, Sara Lega, (unknown), (unknown), (unknown), Diane R. Mould	3
13	PD-006 Higher Vedolizumab Trough Levels Associated with Remission in Inflammatory Bowel Disease (IBD) Patients During Maintenance Therapy 2017 ·Inflammatory Bowel Diseases ·Ryan C. Ungaro, Jacqueline Jossen, Becky L. Phan, (unknown), Anjali Jain, Snehal Naik, Marla C. Dubinsky	3
14	Self-efficacy and Resilience Are Useful Predictors of Transition Readiness Scores in Adolescents with Inflammatory Bowel Diseases 2017 ·Inflammatory Bowel Diseases ·Katrine Carlsen, (unknown), (unknown), Becky L. Phan, Nanci Pittman, Keith Benkov, Marla C. Dubinsky, Laurie Keefer	74
15	Higher Vedolizumab Trough Levels Associated with Remission in Inflammatory Bowel Disease (IBD) During Maintenance Therapy 2017 ·Gastroenterology ·Ryan C. Ungaro, Jacqueline Jossen, Becky L. Phan, (unknown), Priya Sehgal, Anjali Jain, Snehal Naik, Marla C. Dubinsky	3
16	Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients 2016 ·The AAPS Journal ·Marla C. Dubinsky, Becky L. Phan, Namita Singh, Shervin Rabizadeh, Diane R. Mould	52
17	Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease 2016 ·Inflammatory Bowel Diseases ·Namita Singh, Shervin Rabizadeh, Jacqueline Jossen, Nanci Pittman, (unknown), (unknown), Becky L. Phan, Jeffrey S. Hyams, Marla C. Dubinsky	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact